Advaxis, Inc.

Quick facts

Phase 2 pipeline

• Axalimogene filolisbac · Oncology
  Lysosomal targeting of tumor cells via Listeria monocytogenes

Phase 1 pipeline

• ADXS-503
• ADXS31-142 · Oncology
  Listeria monocytogenes-based immunotherapy targeting MUC1
• ADXS31-164 · Oncology
  Listeria monocytogenes-based immunotherapy targeting MUC1

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Advaxis, Inc. portfolio CI brief
• Advaxis, Inc. pipeline updates RSS